Boston, April 06, 2026 (GLOBE NEWSWIRE) -- The global market for validation, calibration and standardization in life sciences is projected to grow from $2.7 billion in 2024 to $3.9 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.7%, according to a new report from BCC Research.

The report, Validation, Calibration, and Standardization in the Life Sciences Market, delivers comprehensive analysis of the services, instruments, consumables and technologies ensuring measurement accuracy, regulatory compliance and product quality across the pharmaceutical, biotechnology and research sectors.

Key Findings

• The market will reach $3.9 billion by 2030, growing at a 6.7% CAGR from a 2024 base of $2.7 billion — driven by intensifying regulatory compliance requirements, the proliferation of complex biologics and advanced therapy medicinal products (ATMPs), and digital transformation across life sciences manufacturing.
• North America leads with 40.5% market share, reflecting the region's stringent FDA regulatory framework, large pharmaceutical manufacturing base and early adoption of digital validation technologies.
• The proliferation of complex biologics and ATMPs is a critical growth driver. Cell and gene therapies, monoclonal antibodies and other advanced biologics require significantly more rigorous validation and calibration protocols than traditional small-molecule drugs, expanding the addressable market.
• Digital transformation and Industry 4.0 are reshaping validation practices, with AI-driven validation platforms, IoT-enabled smart calibration systems, digital twins for bioprocess standardization and cloud-based GxP compliance platforms replacing traditional paper-based quality systems.
• The competitive landscape includes instrumentation leaders and specialized service providers, including Advantest, Beckman Coulter, Dassault Systèmes, Endress+Hauser, Harvard Bioscience, IBM, Insight Calibration Services, SGS, Tektronix, Thermo Fisher Scientific, Transcat, Trescal, Vaisala and Valgenesis.

Market Drivers

Several structural forces are accelerating market growth. Regulatory agencies worldwide are tightening requirements for equipment qualification, process validation and data integrity — creating non-discretionary demand for calibration and validation services. The rapid expansion of biologics and ATMP manufacturing is introducing new complexity to quality assurance workflows. And the transition from paper-based to digital validation lifecycle management systems is driving both efficiency gains and new technology investment across the industry.

Investment Considerations

Validation, calibration and standardization represents essential infrastructure spending for life sciences companies — demand is driven by regulatory mandates rather than discretionary budgets, providing resilience through economic cycles. The shift toward digital and cloud-based validation platforms, combined with the growing complexity of biopharmaceutical manufacturing, creates opportunities for technology providers that can integrate AI, IoT and digital twin capabilities into compliance workflows.

About the Report

Validation, Calibration, and Standardization in the Life Sciences Market provides detailed market sizing, segmentation by service provider, service type, product type, end user and geography, competitive landscape analysis, technology assessment and strategic forecasting through 2030.

For more information or to download the report, visit https://www.bccresearch.com/market-research/biotechnology/validation-calibration-standardization-life-sciences.html

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process.

BCC Research LLC
50 Milk St., Ste. 16, Boston, MA 02109
press@bccresearch.com  |  +1 781-489-7301
www.bccresearch.com